Biocon surges as its arm gets USFDA’s nod for Dapagliflozin Tablets

[ad_1] Mumbai, April 8 (Udaipur Kiran): Biocon is currently trading at Rs. 345.50, up by 5.35 points or 1.57% from its previous closing of Rs. 340.15 on the BSE. The scrip opened at Rs. 349.10 and has touched a high and low of Rs. 351.45 and Rs. 344.30 respectively. So far 1126885 shares were traded […]

Biocon Rises After Launching GLP-1 Peptide Liraglutide in the Netherlands | Udaipur Kiran

[ad_1] Mumbai, 16 December (Udaipur Kiran) — Shares of Biocon moved higher on Monday after the company announced the launch of its GLP-1 peptide, Liraglutide, in the Netherlands for diabetes and obesity management. The stock was trading at Rs. 391.30, up 1.20% from its previous close of Rs. 386.65. It opened at Rs. 387.45 and […]

Biocon Gains Over 1% as Subsidiary Signs Settlement and License Deal with Amgen | Udaipur Kiran

[ad_1] Mumbai (Udaipur Kiran News): Shares of Biocon Ltd rose over 1.6% in Wednesday’s trading session after its subsidiary, Biocon Biologics, signed a settlement and license agreement with Amgen Inc. paving the way for the commercial launch of its biosimilar drugs Bosaya (denosumab-kyqq) and Aukelso (denosumab-kyqq) in the United States. The stock was trading at […]

Trump’s 100% tariffs on pharma: Sun Pharma, Biocon, Cipla & other pharmaceutical stocks tank; jitters on D-Street

[ad_1] Several prominent Indian pharmaceutical firms, including Sun Pharma, Dr. Reddy’s Laboratories, Cipla, Lupin, Aurobindo Pharma, and Zydus Lifesciences, maintain substantial export operations to the USA. (AI image) Pharma stocks hit by Trump’s tariffs: Pharmaceutical stocks declined sharply by up to 5% on Friday, September 26, following US President Donald Trump’s declaration of imposing 100% […]